Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |